184 related articles for article (PubMed ID: 1516484)
41. Comparative clinical reliability of fasting plasma glucose and glycosylated hemoglobin in non-insulin-dependent diabetes mellitus.
Pecoraro RE; Koepsell TD; Chen MS; Lipsky BA; Belcher DW; Inui TS
Diabetes Care; 1986; 9(4):370-5. PubMed ID: 3743312
[TBL] [Abstract][Full Text] [Related]
42. The glycemic index: similarity of values derived in insulin-dependent and non-insulin-dependent diabetic patients.
Wolever TM; Jenkins DJ; Josse RG; Wong GS; Lee R
J Am Coll Nutr; 1987 Aug; 6(4):295-305. PubMed ID: 3611527
[TBL] [Abstract][Full Text] [Related]
43. Parameters of altered plasma glucose levels during short intervals in diabetic patients.
Inoue W; Tomino Y; Miura M; Yagame M; Watanabe S; Tamura S; Kaneshige H; Nomoto Y; Sakai H
Tokai J Exp Clin Med; 1986 Mar; 11(1):67-70. PubMed ID: 3810694
[TBL] [Abstract][Full Text] [Related]
44. Immunoradiometric assay of insulin, intact proinsulin and 32-33 split proinsulin and radioimmunoassay of insulin in diet-treated type 2 (non-insulin-dependent) diabetic subjects.
Clark PM; Levy JC; Cox L; Burnett M; Turner RC; Hales CN
Diabetologia; 1992 May; 35(5):469-74. PubMed ID: 1521730
[TBL] [Abstract][Full Text] [Related]
45. Plasma insulin, C-peptide, and proinsulin concentrations in obese and nonobese individuals with varying degrees of glucose tolerance.
Reaven GM; Chen YD; Hollenbeck CB; Sheu WH; Ostrega D; Polonsky KS
J Clin Endocrinol Metab; 1993 Jan; 76(1):44-8. PubMed ID: 8421101
[TBL] [Abstract][Full Text] [Related]
46. [Control of the metabolic state of diabetic patients by determining the concentration of serum glycosylated proteins (the fructosamine test)].
Dogaru C; Deutsch G; Negrişanu G; Moldovan I; Băcanu G
Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1989; 41(5):449-58. PubMed ID: 2575276
[TBL] [Abstract][Full Text] [Related]
47. Glycated Serum Protein Genetics and Pleiotropy with Cardiometabolic Risk Factors.
Johnson MP; Keyho R; Blackburn NB; Laston S; Kumar S; Peralta J; Thapa SS; Towne B; Subedi J; Blangero J; Williams-Blangero S
J Diabetes Res; 2019; 2019():2310235. PubMed ID: 31089471
[TBL] [Abstract][Full Text] [Related]
48. Total serum glycosylated proteins in detection and monitoring of gestational diabetes.
Cefalu WT; Prather KL; Chester DL; Wheeler CJ; Biswas M; Pernoll ML
Diabetes Care; 1990 Aug; 13(8):872-5. PubMed ID: 2209322
[TBL] [Abstract][Full Text] [Related]
49. Changes in glycosylated proteins in diabetic and non-diabetic patients with and without cardiovascular complications.
Gul A; Rahman MA
Asia Pac J Clin Nutr; 2003; 12(3):277-81. PubMed ID: 14505990
[TBL] [Abstract][Full Text] [Related]
50. Comparisons of home blood glucose testing and glycated protein measurements.
Lee PD; Sherman LD; O'Day MR; Rognerud CL; Ou CN
Diabetes Res Clin Pract; 1992 Apr; 16(1):53-62. PubMed ID: 1576932
[TBL] [Abstract][Full Text] [Related]
51. [Comparative study on the levels of glycosylated hemoglobin and fasting plasma glucose in diabetics].
Xiang KS
Zhonghua Yi Xue Za Zhi; 1985 Aug; 65(8):449-53. PubMed ID: 3931870
[No Abstract] [Full Text] [Related]
52. Importance of glucose control.
Edelman SV
Med Clin North Am; 1998 Jul; 82(4):665-87. PubMed ID: 9706116
[TBL] [Abstract][Full Text] [Related]
53. Safety and efficacy of normalizing fasting glucose with bedtime NPH insulin alone in NIDDM.
Cusi K; Cunningham GR; Comstock JP
Diabetes Care; 1995 Jun; 18(6):843-51. PubMed ID: 7555511
[TBL] [Abstract][Full Text] [Related]
54. Differential effects of ambient blood glucose level and degree of obesity on basal serum C-peptide level and the C-peptide response to glucose and glucagon in non-insulin-dependent diabetes mellitus.
Park SW; Ihm SH; Yoo HJ; Park JY; Lee KU
Diabetes Res Clin Pract; 1997 Sep; 37(3):165-71. PubMed ID: 9306037
[TBL] [Abstract][Full Text] [Related]
55. A comparison of direct measures of glycaemia and glycated blood proteins in insulin-dependent diabetes mellitus.
Winocour PH; Bhatnagar D; Kalsi P; Hillier VF; Anderson DC
Clin Biochem; 1989 Dec; 22(6):457-61. PubMed ID: 2692874
[TBL] [Abstract][Full Text] [Related]
56. Veterans Affairs Cooperative Study on glycemic control and complications in type II diabetes (VA CSDM). Results of the feasibility trial. Veterans Affairs Cooperative Study in Type II Diabetes.
Abraira C; Colwell JA; Nuttall FQ; Sawin CT; Nagel NJ; Comstock JP; Emanuele NV; Levin SR; Henderson W; Lee HS
Diabetes Care; 1995 Aug; 18(8):1113-23. PubMed ID: 7587846
[TBL] [Abstract][Full Text] [Related]
57. 4-Phenyl butyric acid does not generally reduce glucose levels in rodent models of diabetes.
Xu TY; Chen RH; Wang P; Zhang RY; Ke SF; Miao CY
Clin Exp Pharmacol Physiol; 2010 Apr; 37(4):441-6. PubMed ID: 19878212
[TBL] [Abstract][Full Text] [Related]
58. Prolactin and beta-endorphin responses to hypoglycemia are reduced in well-controlled insulin-dependent diabetes mellitus.
Kinsley BT; Levy CJ; Simonson DC
Metabolism; 1996 Nov; 45(11):1434-40. PubMed ID: 8931651
[TBL] [Abstract][Full Text] [Related]
59. Measurement of serum glycosylated proteins and glycosylated low density lipoprotein fraction in diabetes mellitus.
Mani I; Patel J; Mani UV
Biochem Med Metab Biol; 1987 Apr; 37(2):184-9. PubMed ID: 3593589
[TBL] [Abstract][Full Text] [Related]
60. [Correlation of glycosylated serum protein and glycosylated hemoglobin in patients with diabetes mellitus type 2 at various stages of metabolic compensation].
Plechanow J; Bartosiewicz W; Szczepanik Z
Pol Arch Med Wewn; 1987 Sep; 78(3):149-53. PubMed ID: 3271294
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
